SCHEMBL7045496

SCHEMBL7045496

COC(=O)Cc1cc(OC)cc(OC)c1C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.45
USP2 O75604 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HPGD P15428 2/20 0.44
KDM4E B2RXH2 3/20 0.43
ABL1 P00519 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
RECQL P46063 1/20 0.43
RIN1 Q13671 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 2/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048092 0.88 CYP3A4 (0.51) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL347816 0.88 KDM4E (0.47) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL7050534 0.84 CYP3A4 (0.42) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL16290680 0.83 CYP3A4 (0.46) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL2865673 0.82 CYP3A4 (0.54) CYP3A4MAPK1HPGDKDM4EMAPT
Methyl 2,4,6-Trimethoxybenzoate SCHEMBL2563067 0.81 CYP3A4 (0.58) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL3831737 0.81 HSD17B10 (0.45) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL6501990 0.81 CYP3A4 (0.51) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL16246149 0.79 HSD17B10 (0.44) CYP3A4USP2MAPK1SMN1; SMN2HPGD
SCHEMBL16993027 0.79 HSD17B10 (0.44) CYP3A4USP2MAPK1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1300403-A1 Process for the manufacture of hypoxyxylerone derivatives Aventis Pharma S.A. (FR) 2003-04-09 EP disclosed